Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando L Martin

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of the American College of Cardiology|May 8, 2010
The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjectsPaul M McKie, Alessandro Cataliotti, Brian D Lahr, et al.
Plos One|December 29, 2012
CD-NP: a novel engineered dual guanylyl cyclase activator with anti-fibrotic actions in the heartFernando L Martin, S Jeson Sangaralingham, Brenda K Huntley, et al.
Hypertension (Dallas, Tex. : 1979)|December 30, 2010
The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic PeptideS Jeson Sangaralingham, Brenda K Huntley, Fernando L Martin, et al.
Hypertension (Dallas, Tex. : 1979)|April 6, 2006
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failurePaul M McKie, Richard J Rodeheffer, Alessandro Cataliotti, et al.
Circulation. Cardiovascular Imaging|June 9, 2012
Cardiac micro-computed tomography imaging of the aging coronary vasculatureS Jeson Sangaralingham, Erik L Ritman, Paul M McKie, et al.
Clinical Pharmacology and Therapeutics|December 12, 2017
A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart FailureRika Kawakami, Candace Y W Lee, Christopher Scott, et al.
Circulation|March 16, 2011
Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive ratsAlessandro Cataliotti, Jason M Tonne, Diego Bellavia, et al.
Circulation|October 8, 2008
Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertensionAlessandro Cataliotti, Horng H Chen, John A Schirger, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 2, 2006
Lack of activation of molecular forms of the BNP system in human grade 1 hypertension and relationship to cardiac hypertrophyPaola Belluardo, Alessandro Cataliotti, Lorena Bonaiuto, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 11, 2011
Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connectionFernando L Martin, Paul M McKie, Alessandro Cataliotti, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of the American College of Cardiology|May 8, 2010
The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjectsPaul M McKie, Alessandro Cataliotti, Brian D Lahr, et al.
Plos One|December 29, 2012
CD-NP: a novel engineered dual guanylyl cyclase activator with anti-fibrotic actions in the heartFernando L Martin, S Jeson Sangaralingham, Brenda K Huntley, et al.
Hypertension (Dallas, Tex. : 1979)|December 30, 2010
The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic PeptideS Jeson Sangaralingham, Brenda K Huntley, Fernando L Martin, et al.
Hypertension (Dallas, Tex. : 1979)|April 6, 2006
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failurePaul M McKie, Richard J Rodeheffer, Alessandro Cataliotti, et al.
Circulation. Cardiovascular Imaging|June 9, 2012
Cardiac micro-computed tomography imaging of the aging coronary vasculatureS Jeson Sangaralingham, Erik L Ritman, Paul M McKie, et al.
Clinical Pharmacology and Therapeutics|December 12, 2017
A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart FailureRika Kawakami, Candace Y W Lee, Christopher Scott, et al.
Circulation|March 16, 2011
Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive ratsAlessandro Cataliotti, Jason M Tonne, Diego Bellavia, et al.
Circulation|October 8, 2008
Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertensionAlessandro Cataliotti, Horng H Chen, John A Schirger, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 2, 2006
Lack of activation of molecular forms of the BNP system in human grade 1 hypertension and relationship to cardiac hypertrophyPaola Belluardo, Alessandro Cataliotti, Lorena Bonaiuto, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 11, 2011
Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connectionFernando L Martin, Paul M McKie, Alessandro Cataliotti, et al.
Pageof 3